A detailed history of Geneos Wealth Management Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 452 shares of NTRA stock, worth $77,712. This represents 0.0% of its overall portfolio holdings.

Number of Shares
452
Previous 535 15.51%
Holding current value
$77,712
Previous $67,000 5.97%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025

SELL
$117.67 - $174.0 $9,766 - $14,442
-83 Reduced 15.51%
452 $71,000
Q3 2024

Nov 14, 2024

BUY
$97.75 - $129.67 $52,296 - $69,373
535 New
535 $67,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.7B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.